...
search icon
blrx-img

BioLineRx Ltd Share Price

BLRX
NAQ
$2.84
+$0.03
(1.07%)
1D
Industry: Biotechnology Sector: Health Care

BioLineRx Ltd Analyst Forecast

BioLineRx Ltd Share Price Chart

BioLineRx Ltd Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$12.23M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
14.94K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.58
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.3 L
$7.77 H
$2.84

About BioLineRx Ltd, Common Stock

BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel. more

Industry: BiotechnologySector: Health Care

BioLineRx Ltd Stock Returns

Time FrameBLRXSectorS&P500
1-Week Return-4.75%0.72%-1.31%
1-Month Return-0.71%1.27%0.78%
3-Month Return-12.46%3.13%3.46%
6-Month Return-26.63%15.81%6.19%
1-Year Return-31.63%8.89%11.68%
3-Year Return-88.29%20.79%71.21%
5-Year Return-97.96%35.89%74.81%
10-Year Return-99.52%138.44%256.59%

BioLineRx Ltd Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue---4.80M28.94M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":16.59,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue934.00K702.00K654.00K3.69M9.26M[{"date":"2020-12-31","value":10.08,"profit":true},{"date":"2021-12-31","value":7.58,"profit":true},{"date":"2022-12-31","value":7.06,"profit":true},{"date":"2023-12-31","value":39.86,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit(934.00K)(702.00K)(654.00K)1.11M19.68M[{"date":"2020-12-31","value":-4.75,"profit":false},{"date":"2021-12-31","value":-3.57,"profit":false},{"date":"2022-12-31","value":-3.32,"profit":false},{"date":"2023-12-31","value":5.63,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin---23.08%67.99%[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":33.95,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses22.93M24.78M29.16M50.80M40.09M[{"date":"2020-12-31","value":45.13,"profit":true},{"date":"2021-12-31","value":48.77,"profit":true},{"date":"2022-12-31","value":57.39,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":78.9,"profit":true}]
Operating Income(22.93M)(24.78M)(29.16M)(49.69M)(20.41M)[{"date":"2020-12-31","value":-2292700000,"profit":false},{"date":"2021-12-31","value":-2477700000,"profit":false},{"date":"2022-12-31","value":-2915700000,"profit":false},{"date":"2023-12-31","value":-4969400000,"profit":false},{"date":"2024-12-31","value":-2040800000,"profit":false}]
Total Non-Operating Income/Expense(8.35M)(2.72M)3.09M(11.08M)3.89M[{"date":"2020-12-31","value":-214.76,"profit":false},{"date":"2021-12-31","value":-70.06,"profit":false},{"date":"2022-12-31","value":79.42,"profit":true},{"date":"2023-12-31","value":-285.03,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(30.02M)(27.05M)(24.95M)(60.61M)(9.22M)[{"date":"2020-12-31","value":-3002100000,"profit":false},{"date":"2021-12-31","value":-2705400000,"profit":false},{"date":"2022-12-31","value":-2495100000,"profit":false},{"date":"2023-12-31","value":-6061400000,"profit":false},{"date":"2024-12-31","value":-922100000,"profit":false}]
Income Taxes911.00K1.09M(4.21M)1.00K-[{"date":"2020-12-31","value":83.58,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-385.87,"profit":false},{"date":"2023-12-31","value":0.09,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(30.93M)(28.14M)(20.75M)(60.62M)-[{"date":"2020-12-31","value":-3093200000,"profit":false},{"date":"2021-12-31","value":-2814400000,"profit":false},{"date":"2022-12-31","value":-2074500000,"profit":false},{"date":"2023-12-31","value":-6061500000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(30.02M)(27.05M)(24.95M)(60.62M)(9.22M)[{"date":"2020-12-31","value":-3002100000,"profit":false},{"date":"2021-12-31","value":-2705400000,"profit":false},{"date":"2022-12-31","value":-2495100000,"profit":false},{"date":"2023-12-31","value":-6061500000,"profit":false},{"date":"2024-12-31","value":-922100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(30.02M)(27.05M)(24.95M)(60.61M)(9.22M)[{"date":"2020-12-31","value":-3002100000,"profit":false},{"date":"2021-12-31","value":-2705400000,"profit":false},{"date":"2022-12-31","value":-2495100000,"profit":false},{"date":"2023-12-31","value":-6061400000,"profit":false},{"date":"2024-12-31","value":-922100000,"profit":false}]
EPS (Diluted)(1.95)(0.70)(0.40)(0.61)(0.08)[{"date":"2020-12-31","value":-195,"profit":false},{"date":"2021-12-31","value":-70,"profit":false},{"date":"2022-12-31","value":-40,"profit":false},{"date":"2023-12-31","value":-61,"profit":false},{"date":"2024-12-31","value":-7.67,"profit":false}]

BioLineRx Ltd Ratios

BioLineRx Ltd Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

BLRX
Current Ratio 2.09
Quick Ratio 1.93

BioLineRx Ltd Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BLRX
ROA (LTM) -15.36%
ROE (LTM) -45.94%

BioLineRx Ltd Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BLRX
Debt Ratio Lower is generally better. Negative is bad. 0.51
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.49

BioLineRx Ltd Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BLRX
Trailing PE NM
Forward PE 93.46
P/S (TTM) 1.04
P/B 0.65
Price/FCF NM
EV/R 0.13
EV/Ebitda 1.11
PEG 0.20

FAQs

What is BioLineRx Ltd share price today?

BioLineRx Ltd (BLRX) share price today is $2.84

Can Indians buy BioLineRx Ltd shares?

Yes, Indians can buy shares of BioLineRx Ltd (BLRX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BLRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of BioLineRx Ltd be purchased?

Yes, you can purchase fractional shares of BioLineRx Ltd (BLRX) via the Vested app. You can start investing in BioLineRx Ltd (BLRX) with a minimum investment of $1.

How to invest in BioLineRx Ltd shares from India?

You can invest in shares of BioLineRx Ltd (BLRX) via Vested in three simple steps:

  • Click on Sign Up or Invest in BLRX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in BioLineRx Ltd shares
What is BioLineRx Ltd 52-week high and low stock price?

The 52-week high price of BioLineRx Ltd (BLRX) is $7.77. The 52-week low price of BioLineRx Ltd (BLRX) is $2.3.

What is BioLineRx Ltd price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of BioLineRx Ltd (BLRX) is

What is BioLineRx Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of BioLineRx Ltd (BLRX) is 0.65

What is BioLineRx Ltd dividend yield?

The dividend yield of BioLineRx Ltd (BLRX) is 0.00%

What is the Market Cap of BioLineRx Ltd?

The market capitalization of BioLineRx Ltd (BLRX) is $12.23M

What is BioLineRx Ltd's stock symbol?

The stock symbol (or ticker) of BioLineRx Ltd is BLRX

How Can Investors Use BioLineRx Ltd Share Price Data for Long-Term Investment Decisions?

Consider the share price of BioLineRx Ltd as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether BioLineRx Ltd has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from BioLineRx Ltd shares for Indian investors?

When investing in BioLineRx Ltd shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the BioLineRx Ltd stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare BioLineRx Ltd share price with other stocks in the same sector?

Rather than merely checking the share price of BioLineRx Ltd and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that BioLineRx Ltd stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top